Home › Atopic Dermatitis (Eczema) › Ohio
Atopic Dermatitis (Eczema) clinical trials in Ohio
10 studies for Atopic Dermatitis (Eczema) are looking for participants at sites in Ohio.
Cities in Ohio
Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
- AMR Clinical - Columbus, OH, Columbus
RecruitingObservational study
Ages 12 to 89 · All sexes · Updated Nov 9, 2026 · NCT07645820A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- Apex Clinical Research Center, LLC. - Lorain, Lorain
- Apex Clinical Research Center, LLC., Mayfield Heights
RecruitingPhase 2
Ages 18 to 64 · All sexes · Updated Nov 5, 2026 · NCT07216027A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Boardman
- Investigational Site, Mason
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07003425This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Dermatology Associates of Mid-Ohio- Site Number : 8400026, Marion
- Dermatologists of Southwest Ohio - Mason- Site Number : 8400050, Mason
RecruitingObservational study
Ages 12 and older · All sexes · Updated Nov 2, 2026 · NCT07290803A Study Evaluating TRIV-573 in Atopic Dermatitis
- Triveni Bio Site #16, Boardman
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 28, 2026 · NCT07782333Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Canton
- Enveda Investigative Site, Mayfield Heights
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT07298395A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- ClinOhio Research Services, Columbus
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 28, 2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 9, Columbus
- Inmagene Site 5, Mayfield Heights
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Aug 12, 2026 · NCT07037901Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
- Cincinnati Children's Hospital Medical Center: Asthma Center, Cincinnati
RecruitingPhase 1
Ages 6 and older · All sexes · Updated Jul 2, 2026 · NCT06504160Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 7081, Dayton
RecruitingObservational study
Ages 12 and older · All sexes · Updated Mar 13, 2026 · NCT06988605From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.